Address
SR One Ltd
161 Washington Street
Suite 500 Eight Tower Bridge
Conshohocken, PA 19428
United States
Phone
Website
Recent investment activity
KANDO id: 19503
Corporate information
Registration country
Company type
The venture capital unit of GlaxoSmithKlineFunding rounds
Actual initial investment stage
Series B (1)
Investment activity status
Active investor
Selected investments
Displaying 1 - 25 of 32| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Cabrellis Pharmaceuticals Corp | Development of important therapies for the treatment of cancer | Series A | |||
|
|
Conforma Therapeutics Corp | Novel drugs company for the selective treatment of cancer. | N/A | |||
|
diaDexus Inc | Biotechnology company focused on the discovery, development & commercialization of novel, patent protected diagnostic product with high clinical value | N/A | |||
|
|
Dicerna Pharmaceuticals Inc | N/A | ||||
|
|
Genocea Biosciences Inc | Series B | ||||
|
|
HTG Molecular Diagnostics Inc | N/A | ||||
|
|
Memory Pharmaceuticals Corp | N/A | ||||
|
|
NeuroTherapeutics Pharma Inc | N/A | ||||
|
|
Nimbus Discovery LLC | A computational technology-based drug discovery company. | Series A | |||
|
|
OncoMed Pharmaceuticals Inc | Biotechnology company focused on scientific discoveries of cancer stem cells in solid tumors. | N/A | |||
|
|
Point Biomedical Inc | Developer of a microsphere that freely circulates when injected into the bloodstream. | Series E | |||
|
|
Principia Biopharma | Discoverer and developer of differentiated small molecule drugs targeting inflammatory/autoimmune diseases as well as cancer. | Series A | |||
|
|
Rib-X Pharmaceuticals Inc | N/A | ||||
|
|
Santarus Inc | Drug company focused on gastrointestinal diseases and disorders. | N/A | |||
|
|
Scion Pharmaceuticals Inc | N/A | ||||
|
|
Scynexis Inc | Provider of drug discovery, development, and manufacturing projects. | N/A | |||
|
|
Semprus BioSciences | Develops implantable and permanently-antimicrobial surface technology that is incorporated into medical devices | Series B | |||
|
|
Sequenom Inc | Biotechnology tools and diagnostics company. | N/A | |||
|
|
SpringLeaf Therapeutics Inc | Develops and manufactures a drug delivery system called the "patch pump" to deliver drugs subcutaneously. | N/A | |||
|
|
Torrey Pines Therapeutics Inc | N/A | ||||
|
|
Addex Pharmaceuticals SA | Switzerland-based drug company focused on CNS disorders | N/A | |||
|
|
Adolor Corp | N/A | ||||
|
|
Aileron Therapeutics Inc | Developing a breakthrough proprietary peptide technology platform | N/A | |||
|
|
Alere Medical Inc | A disease management company focused on internet-based medical monitoring systems for patients with chronic diseases. | N/A | |||
|
|
Auxogyn Inc | Series B |